Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Macular Edema(DME)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07705555
What this trial is testing

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Who this might be right for
Diabetic RetinopathyMacular Edema
Merck Sharp & Dohme LLC 960
Post-approval studies (Phase 4)UnknownNCT04464694
What this trial is testing

Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema

Who this might be right for
Proliferative Diabetic RetinopathyDiabetic Macular Edema
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142
Large-scale testing (Phase 3)Not Yet RecruitingNCT07842016
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-03)

Who this might be right for
Diabetic Macular Edema (DME)
Ollin Biosciences, Inc. 450
Testing effectiveness (Phase 2)Study completedNCT00071773
What this trial is testing

A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 263
Large-scale testing (Phase 3)Study completedNCT02818998
What this trial is testing

Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

Who this might be right for
Macular Edema
Bayer 463
Post-approval studies (Phase 4)Study completedNCT05959304
What this trial is testing

Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 66
Post-approval studies (Phase 4)Study completedNCT02392364
What this trial is testing

Variable Interval Versus Set Interval Aflibercept for DME

Who this might be right for
Cystoid Macular EdemaDiabetic Macular Edema
California Retina Consultants 50
Large-scale testing (Phase 3)UnknownNCT02194634
What this trial is testing

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Who this might be right for
Diabetic Macular Edema
Chengdu Kanghong Biotech Co., Ltd. 248
Post-approval studies (Phase 4)Study completedNCT02633852
What this trial is testing

Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
Hadassah Medical Organization 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07612904
What this trial is testing

Zhuochuming®-3T&E-DME Study (Treatment-naïve Patients)

Who this might be right for
Diabetic Macular Edema (DME)
The Third Peoples Hospital of Dalian 186
Large-scale testing (Phase 3)Study completedNCT01748487
What this trial is testing

The Effect of Intravitreal Ozurdex on DME After Cataract Surgery

Who this might be right for
Diabetic Macular Edema
University Health Network, Toronto 24
Very early researchLooking for participantsNCT07362927
What this trial is testing

Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients

Who this might be right for
Diabetic Macular Edema (DME)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 32
Not applicableStudy completedNCT00687154
What this trial is testing

Observational Study of DME Following Scatter Laser Photocoagulation

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 155
Testing effectiveness (Phase 2)WithdrawnNCT03384524
What this trial is testing

Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME

Who this might be right for
Diabetic Macular Edema
Andrew Moshfeghi, MD, MBA
Testing effectiveness (Phase 2)Study completedNCT04857996
What this trial is testing

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

Who this might be right for
Diabetic Macular Edema (DME)
Unity Biotechnology, Inc. 65
Large-scale testing (Phase 3)Study completedNCT03660345
What this trial is testing

PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

Who this might be right for
Diabetic RetinopathyMacular Edema
Rush Eye Associates 11
Large-scale testing (Phase 3)Study completedNCT01135914
What this trial is testing

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 241
Large-scale testing (Phase 3)Study completedNCT00687804
What this trial is testing

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study

Who this might be right for
Diabetic Macular Edema
Novartis 345
Post-approval studies (Phase 4)WithdrawnNCT02878681
What this trial is testing

24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.

Who this might be right for
Visual Impairment Due to Diabetic Macular Edema
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT05712720
What this trial is testing

Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Rezolute 94
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation